Head-to-Head

Moderna, Inc. Common Stock vs. Repligen Corp

MRNA

Moderna, Inc. Common Stock

$220.83 -0.40%

VS RGEN

Repligen Corp

$172.95 -2.26%

Moderna, Inc. Common Stock (MRNA) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

MRNARGEN
Market Cap $88.52 billion $11.23 billion

MRNA leads on 1 of 1 size & scale factors.

Risk & Sentiment

MRNARGEN
Short Interest 0.01% 7.13%

MRNA leads on 1 of 1 risk & sentiment factors.

Dig deeper: MRNA overview, MRNA financials, RGEN overview, RGEN financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.